Search

Your search keyword '"Kinoshita, Shiori"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Kinoshita, Shiori" Remove constraint Author: "Kinoshita, Shiori"
134 results on '"Kinoshita, Shiori"'

Search Results

2. Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution

3. A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma

4. Loss of function in NSD2 causes DNA methylation signature similar to that in Wolf-Hirschhorn syndrome

9. Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone.

11. Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin

13. P820: POTENTIAL IMMUNOSUPPRESSIVE EFFECT OF EXTRACELLULAR VESICLES FROM PATIENTS WITH MULTIPLE MYELOMA

15. Low‐dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation.

16. Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia

17. Data from Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma

18. Supplementary Figure 1, Tables S1-6 from Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma

19. Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features

21. DNA methylation signature inNSD2loss-of-function variants appeared similar to that in Wolf-Hirschhorn syndrome

22. Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients

23. Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients.

30. Volunteer unrelated donor cell‐derived acute myeloid leukemia with RUNX1‐RUNX1T1

31. Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study

32. Clinical significance of tryptophan catabolism in follicular lymphoma

33. Expression, mutation, and methylation of cereblon‐pathway genes at pre‐ and post‐lenalidomide treatment in multiple myeloma

34. Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy

37. Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma

38. Human T‐cell lymphotropic/leukemia virus type 1 ( HTLV ‐1) Tax‐specific T‐cell exhaustion in HTLV ‐1‐infected individuals

39. Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma

40. Potent antitumor effect of combination therapy with sub‑optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma

41. Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits

42. Clinical significance of tryptophan catabolism in Hodgkin lymphoma

44. Anti-Myeloma Activity of a Syringolin Analog: A Dual 20S Proteasome Inhibitor of Beta 2 and 5 Subunits

45. Identification of Circulating Serum microRNAs As Novel Biomarkers Predicting Disease Progression and Sensitivity to Bortezomib Treatment in Multiple Myeloma

47. Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma

48. Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis

49. Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma

50. Clinical significance of tryptophan catabolism in Hodgkin lymphoma.

Catalog

Books, media, physical & digital resources